2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease

PO Katz, KB Dunbar, FH Schnoll-Sussman… - Official journal of the …, 2022 - journals.lww.com
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis

B Levis, Y Sun, C He, Y Wu, A Krishnan, PM Bhandari… - Jama, 2020 - jamanetwork.com
Importance The Patient Health Questionnaire depression module (PHQ-9) is a 9-item self-
administered instrument used for detecting depression and assessing severity of …

Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis

JS Nirwan, SS Hasan, ZUD Babar, BR Conway… - Scientific reports, 2020 - nature.com
Although gastro-oesophageal reflux disease (GORD) is a common medical complaint, there
is currently no consensus on the global prevalence of GORD. The aim of this study was to …

Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis

LH Eusebi, R Ratnakumaran, Y Yuan… - Gut, 2018 - gut.bmj.com
Objectives Gastro-oesophageal reflux symptoms are common in the community, but there
has been no definitive systematic review and meta-analysis of data from all studies to …

[HTML][HTML] 25 years of proton pump inhibitors: a comprehensive review

DS Strand, D Kim, DA Peura - Gut and liver, 2017 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have
since proven to be invaluable, safe, and effective agents for the management of a variety of …

[HTML][HTML] Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

RC Fitzgerald, M di Pietro, M O'Donovan, R Maroni… - The Lancet, 2020 - thelancet.com
Summary Background Treatment of dysplastic Barrett's oesophagus prevents progression to
adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is …

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

HB El-Serag, S Sweet, CC Winchester, J Dent - Gut, 2014 - gut.bmj.com
Objective To update the findings of the 2005 systematic review of population-based studies
assessing the epidemiology of gastro-oesophageal reflux disease (GERD). Design PubMed …

Oesophageal carcinoma

A Pennathur, MK Gibson, BA Jobe, JD Luketich - The Lancet, 2013 - thelancet.com
Oesophageal carcinoma affects more than 450 000 people worldwide and the incidence is
rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal …

Guidelines for the diagnosis and management of gastroesophageal reflux disease

PO Katz, LB Gerson, MF Vela - … journal of the American College of …, 2013 - journals.lww.com
Gastroesophageal reflux disease (GERD) is arguably the most common disease
encountered by the gastroenterologist. It is equally likely that the primary care providers will …